MyVitalC (ESS60 in Extra Virgin Olive Oil): Participants will take 1 teaspoon (5 mL) of MyVitalC, ESS60 in extra virgin olive oil, orally once daily in the morning, with or without food, for six weeks. Daily intake is logged within the study platform.
Study summary
Sleep disturbance and recurring headaches can negatively affect daily functioning, mood, and productivity. MyVitalC (ESS60 in extra virgin olive oil) is a commercially available dietary supplement that has generated anecdotal claims related to sleep quality and headache relief; however, human data remain limited.
This real-world observational study is designed to help participants evaluate whether use of MyVitalC is associated with changes in sleep disturbance and headache frequency or severity in their own daily lives. Participants will complete a four-week baseline observation period without the intervention, followed by six weeks of daily MyVitalC use, with weekly self-reported assessments. Participants serve as their own control, allowing for within-person comparison of outcomes before and during product use.
Eligibility
Sex
ALL
Min age
—
Max age
—
Healthy volunteers
Accepted
Inclusion Criteria:
* Adults of legal age of consent
* Able to provide informed consent
* Willing to complete weekly assessments and daily logs
* Able to purchase and use the study product
Exclusion Criteria:
* Have known allergies to olive oil or product components
* Are pregnant or breastfeeding
* Have severe or chronic headache disorders
* Have significant gastrointestinal conditions
* Have medical conditions that could be exacerbated by supplement use
* Have concerns about dizziness, fatigue, or mood disturbances
* Are subject to organizational or legal restrictions on supplement use
Primary outcome measure(s)
Change in Sleep Disturbance — Weekly during baseline (4 weeks) and weekly during intervention (6 weeks) Measure: PROMIS Sleep Disturbance Scale Description: Assesses perceived sleep quality, sleep depth, and sleep-related difficulties. Higher scores indicate greater sleep disturbance.
Change in Headache Frequency — Weekly during baseline and intervention, and on day 70 (end of study) Measure: Weekly Headache Check-In (frequency count)
Description: Number of headaches experienced in the past 7 days.
Change in Headache Severity — Weekly during baseline and intervention, and on day 70 (end of study) Measure: Weekly Headache Check-In (severity rating) Description: Participant-reported severity of the worst headache experienced during the past 7 days.
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
We use cookies to analyse site traffic and improve your experience. With your consent, we may also use cookies for advertising. You can change your choice at any time on our Cookie Policy page. See also our Privacy Policy.